A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

September 4, 2019

Study Completion Date

December 20, 2019

Conditions

Erythroleukoplakia of MouthVerrucous Hyperplasia of Oral Mucosa

Interventions

DRUG

Radion™-pdt

The Radion™-pdt will be applied topically to the lesion. The Radion™-pdt applied dosage is about 0.1 mL/cm\^2 and properly cover the entire lesion.

Trial Locations (1)

National Taiwan University Hospital, Taipei

All Listed Sponsors

lead

Pharma Power Biotec Co., Ltd.

INDUSTRY

NCT03279744 - A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion | Biotech Hunter | Biotech Hunter